Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Breast Neoplasms 118Neoplasms 110Lung Neoplasms 65Colorectal Neoplasms 52Prostatic Neoplasms 46Carcinoma, Non-Small-Cell Lung 46Pancreatic Neoplasms 34Melanoma 33Ovarian Neoplasms 29Neoplastic Cells, Circulating 29Head and Neck Neoplasms 27Uterine Cervical Neoplasms 23Multiple Myeloma 20Glioma 20Colonic Neoplasms 20Sarcoma 19Carcinoma, Hepatocellular 19Leukemia, Myeloid, Acute 18Neoplasm Metastasis 17Lymphoma 15Glioblastoma 15Esophageal Neoplasms 15Squamous Cell Carcinoma of Head and Neck 14Hematologic Neoplasms 14Leukemia 13Endometrial Neoplasms 13Myelodysplastic Syndromes 11Kidney Neoplasms 11Gastrointestinal Neoplasms 11Carcinoma, Renal Cell 11

Interventions

Interleukin-7 2efineptakin alfa 1angiotensin I (1-7) 1Transplantation 1Thymalfasin 1Sodium Chloride 1SARS-CoV-2 inactivated vaccines 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Injections 1Fingolimod Hydrochloride 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphopenia × Blood Specimen Collection × Clear all
NCT03549546 2019-07-26

POIR

Centre Hospitalier Universitaire de Saint Etienne

Phase NA Completed
31 enrolled
Thoracic

Diabetes Mellitus, Insulin-Dependent, 12, Lung Neoplasms, Lymphopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡